Log In
Print this Print this

GALE-302 (formerly J65)

  Manage Alerts
Collapse Summary General Information
Company Galena Biopharma Inc.
DescriptionAttenuated folate binding protein-E39' (FBP) vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationOvarian cancer
Indication DetailsPrevent recurrence of endometrial or ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today